A hybrid structure determination approach to investigate the druggability of the nucleocapsid protein of SARS-CoV-2
Nucleic Acids Research · 2023
DOI: 10.1093/nar/gkad195 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2023. Verfasst von Giacomo Padroni und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biochemistry, Department of Biology, ETH Zurich, Hönggerbergring 64, 8093 Zürich, Switzerland. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, Coronavirus Nucleocapsid Proteins, COVID-19 Drug Treatment. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Swiss National Science Foundation, SNSF.
Abstract (Originalsprache)
The pandemic caused by SARS-CoV-2 has called for concerted efforts to generate new insights into the biology of betacoronaviruses to inform drug screening and development. Here, we establish a workflow to determine the RNA recognition and druggability of the nucleocapsid N-protein of SARS-CoV-2, a highly abundant protein crucial for the viral life cycle. We use a synergistic method that combines NMR spectroscopy and protein-RNA cross-linking coupled to mass spectrometry to quickly determine the RNA binding of two RNA recognition domains of the N-protein. Finally, we explore the druggability of these domains by performing an NMR fragment screening. This workflow identified small molecule chemotypes that bind to RNA binding interfaces and that have promising properties for further fragment expansion and drug development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Biochemistry, Department of Biology, ETH Zurich, Hönggerbergring 64, 8093 Zürich, Switzerland.
- Institute of Molecular Systems Biology, Department of Biology, ETH Zurich, Otto-Stern-Weg 3, 8093 Zürich, Switzerland.
- Biomolecular NMR Spectroscopy Platform, ETH Zurich, Hönggerbergring 64, 8093 Zürich, Switzerland.
ORCID-Profile: Frederic H-T Allain
Förderung
- Swiss National Science Foundation
- SNSF
Zitieren
APA
Padroni, G., Bikaki, M., Novakovic, M., Wolter, A. C., Rüdisser, S. H., Gossert, A. D., Leitner, A., & Allain, F. H. (2023). A hybrid structure determination approach to investigate the druggability of the nucleocapsid protein of SARS-CoV-2. Nucleic Acids Research. https://doi.org/10.1093/nar/gkad195
Vancouver
Padroni G, Bikaki M, Novakovic M, Wolter AC, Rüdisser SH, Gossert AD, et al. A hybrid structure determination approach to investigate the druggability of the nucleocapsid protein of SARS-CoV-2. Nucleic Acids Research. 2023. doi:10.1093/nar/gkad195
BibTeX
@article{Padroni2023,
author = {Padroni, Giacomo and Bikaki, Maria and Novakovic, Mihajlo and Wolter, Antje C and Rüdisser, Simon H and Gossert, Alvar D and Leitner, Alexander and Allain, Frederic H-T},
title = {A hybrid structure determination approach to investigate the druggability of the nucleocapsid protein of SARS-CoV-2},
journal = {Nucleic Acids Research},
year = {2023},
doi = {10.1093/nar/gkad195}
}
EUVIMED